Generation of two CASK patient-derived human induced pluripotent stem cell lines to study CASK-related disorders
First-of-their-kind patient stem cells now model a rare severe epilepsy syndrome, creating platforms to understand disease and test new drugs.
Two iPSC lines derived from CASK mutation patients were generated and validated, providing the first patient-specific human cellular models for CASK-related intellectual disability, a rare X-linked syndrome causing progressive microcephaly and severe epileptic encephalopathy. These iPSC resources enable mechanistic investigation of CASK function in human neurons and serve as platforms for drug screening in a disease with no approved disease-modifying therapies.
What the study was
- Study design
- Patient-derived iPSC line generation and characterization for CASK-related intellectual disability
- Population
- Patient-derived iPSC lines from CASK mutation carriers
- Category
- Drug Development
- Maturity
- Exploratory
- Journal
- Stem Cell Res
Why it surfaced
Patient-derived iPSC disease models for ultra-rare CASK-related disorder; enables mechanistic study and drug screening for a neurological rare disease with extreme unmet need and no current disease-modifying treatment.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.